|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2004-11-29
|
|
pubmed:abstractText |
Hilar cholangiocarcinoma is associated with low resectability and poor survival. The aim of this study was to evaluate the roles of matrix metalloproteinases-2 (MMP-2) and its tissue inhibitor of metalloproteinase-2(TIMP-2) in tumor invasion or as a prognostic factor in patients with human hilar cholangiocarcinoma.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1499-3872
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
3
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
599-602
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15567754-Bile Duct Neoplasms,
pubmed-meshheading:15567754-Bile Ducts, Intrahepatic,
pubmed-meshheading:15567754-Cholangiocarcinoma,
pubmed-meshheading:15567754-Humans,
pubmed-meshheading:15567754-Image Processing, Computer-Assisted,
pubmed-meshheading:15567754-Immunohistochemistry,
pubmed-meshheading:15567754-Matrix Metalloproteinase 2,
pubmed-meshheading:15567754-Staining and Labeling,
pubmed-meshheading:15567754-Tissue Inhibitor of Metalloproteinase-2
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
The ratio of MMP-2 to TIMP-2 in hilar cholangiocarcinoma: a semi-quantitative study.
|
|
pubmed:affiliation |
Department of Hepatobiliary Surgery of General Airforce of Hospital, Beijing 100036, China. fengweiairforce@yahoo.com.cn
|
|
pubmed:publicationType |
Journal Article
|
